Genesis of Scleroderma: Role of Environmental Factors in 100 Patients With Scleroderma and 300 Controls
NCT ID: NCT00213525
Last Updated: 2015-02-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2004-10-31
2008-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This prompted us to conduct this prospective, case-control, multicentric study, including 2 groups of subjects:
* 100 patients with scleroderma
* 300 sex- and age-matched healthy controls. The aim of our study is to determine whether exposure to toxics is higher in patients with scleroderma compared with healthy controls.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Calcinosis in a Single-Center Scleroderma Population
NCT02062125
Clinical and Paraclinical Characteristics of the Systemic Scleroderma Cohort According to the Criteria ACR 2013 and the History of Professional Exposure or of Agricultural Environment
NCT03262922
Pathogenic Mechanisms Involved in the Initiation and Progression of Systemic Sclerosis
NCT07015060
Western Sweden Systemic Sclerosis Project
NCT07345052
Stem Cell Factor, a Potential Biological Marker of Skin Involvement in Systemic Sclerosis?
NCT05482594
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* a standardized questionnaire about "cursus laboris" at initial inclusion
* a search for toxics in blood, urine and hair: at initial exvaluation, 6 month and 2 year-follow-up
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients With Scleroderma
Assessments of questionnary for environmental factors research
Questionnary for environmental factors research
Questionnary for environmental factors research
Healthy Controls
Assessments of questionnary for environmental factors research
Questionnary for environmental factors research
Questionnary for environmental factors research
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnary for environmental factors research
Questionnary for environmental factors research
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age range : 18 to 76 years
* written consent
Exclusion Criteria
* pregnant women
* patients with psychiatric conditions
* unwritten consent
18 Years
76 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Rouen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Isabelle MARIE, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Rouen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rouen University Hospital
Rouen, Rouen Cedex, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2002/039/HP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.